Appco Pharma LLC
Appco Pharma LLC appears in FDA public data with 6 recalls, 0 510(k) clearances, 13 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0419-2026, Class II) was initiated on March 27, 2026.
Summary
- Total Recalls
- 6
- 510(k) Clearances
- 0
- Inspections
- 13
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0419-2026 | Class II | Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharm | March 27, 2026 |
| D-0420-2026 | Class II | Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Phar | March 27, 2026 |
| D-0421-2026 | Class II | Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharm | March 27, 2026 |
| D-0208-2025 | Class III | Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, | January 16, 2025 |
| D-0649-2020 | Class II | Ranitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDC 625 | January 7, 2020 |
| D-0648-2020 | Class II | Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway | January 7, 2020 |